Taiyen Biotech Co., Ltd. - Laporan Laba Rugi (TTM)

Taiyen Biotech Co., Ltd.
TW ˙ TWSE ˙ TW0001737005
NT$ 32.35 ↑0.05 (0.15%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Taiyen Biotech Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 3,008 3,130 3,196 3,391 3,758 4,096 4,229 4,116 3,969 3,614 3,555 3,541 3,486 3,409 3,357 3,302 3,220 3,238 3,244 3,298
Change (%) 4.08 2.10 6.11 10.83 8.97 3.25 -2.66 -3.59 -8.95 -1.61 -0.41 -1.55 -2.21 -1.52 -1.64 -2.50 0.58 0.18 1.65
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,756 1,823 1,864 2,039 2,369 2,722 2,849 2,836 2,660 2,337 2,277 2,270 2,203 2,151 2,095 1,935 1,915 1,917 1,933 1,962
Change (%) 3.79 2.25 9.43 16.15 14.93 4.66 -0.46 -6.22 -12.14 -2.55 -0.35 -2.93 -2.35 -2.60 -7.64 -1.08 0.14 0.80 1.53
% of Revenue 58.39 58.23 58.32 60.14 63.03 66.47 67.38 68.90 67.02 64.67 64.06 64.10 63.20 63.11 62.42 58.61 59.47 59.21 59.57 59.50
Gross Operating Profit 1,251 1,308 1,332 1,352 1,390 1,373 1,379 1,280 1,309 1,277 1,278 1,271 1,283 1,257 1,262 1,367 1,305 1,321 1,311 1,335
Change (%) 4.48 1.88 1.47 2.81 -1.18 0.44 -7.20 2.24 -2.45 0.11 -0.53 0.91 -1.96 0.33 8.32 -4.52 1.23 -0.72 1.82
% of Revenue 41.61 41.77 41.68 39.86 36.97 33.53 32.62 31.10 32.98 35.33 35.94 35.90 36.80 36.89 37.58 41.39 40.53 40.79 40.43 40.50
SG&A 767 770 769 754 760 786 790 785 785 771 775 792 816 876 918 947 934 920 898 881
Change (%) 0.38 -0.20 -1.87 0.74 3.48 0.42 -0.66 0.01 -1.75 0.52 2.22 2.95 7.36 4.84 3.15 -1.36 -1.54 -2.37 -1.84
% of Revenue 25.51 24.61 24.05 22.25 20.22 19.20 18.68 19.06 19.77 21.33 21.80 22.37 23.40 25.68 27.34 28.68 29.01 28.40 27.68 26.73
R&D 82 74 68 56 56 58 58 59 59 61 61 62 61 60 58 57 55 55 55 56
Change (%) -10.08 -8.65 -17.52 0.80 2.51 1.24 0.51 1.36 2.07 -0.19 1.64 -0.27 -1.39 -3.82 -1.66 -3.18 -1.25 1.12 0.79
% of Revenue 2.74 2.36 2.11 1.64 1.49 1.41 1.38 1.42 1.50 1.68 1.70 1.74 1.76 1.77 1.73 1.73 1.72 1.69 1.71 1.69
OpEx 2,606 2,667 2,700 2,850 3,185 3,566 3,697 3,679 3,504 3,169 3,113 3,123 3,080 3,087 3,072 2,940 2,904 2,892 2,886 2,899
Change (%) 2.35 1.24 5.54 11.77 11.98 3.67 -0.49 -4.77 -9.57 -1.75 0.33 -1.39 0.24 -0.51 -4.30 -1.21 -0.43 -0.20 0.47
% of Revenue 86.64 85.20 84.48 84.03 84.74 87.08 87.44 89.39 88.29 87.68 87.55 88.21 88.36 90.57 91.50 89.02 90.20 89.30 88.96 87.92
Operating Income 402 463 496 542 573 529 531 437 465 445 443 418 406 321 285 362 315 347 358 398
Change (%) 15.30 7.03 9.22 5.89 -7.72 0.40 -17.77 6.37 -4.23 -0.57 -5.64 -2.80 -20.79 -11.19 26.96 -12.96 9.85 3.39 11.17
% of Revenue 13.36 14.80 15.52 15.97 15.26 12.92 12.56 10.61 11.71 12.32 12.45 11.79 11.64 9.43 8.50 10.98 9.80 10.70 11.04 12.08
Interest Expense -3 -4 -4 -5 -5 -6 -6 -6 -5 -5 -4 -3 -3 -3 -4 -4 -5 -6 -7 -8
Change (%) 4.61 12.21 11.42 18.42 11.34 0.34 -1.01 -7.40 -17.24 -14.22 -21.91 -7.49 19.48 12.03 17.16 4.55 37.90 6.34 13.31
% of Revenue -0.11 -0.12 -0.13 -0.13 -0.14 -0.15 -0.14 -0.14 -0.14 -0.13 -0.11 -0.09 -0.08 -0.10 -0.11 -0.13 -0.14 -0.20 -0.21 -0.23
Net Income 318 365 402 427 431 393 418 357 419 427 408 399 389 300 297 358 298 372 364 353
Change (%) 14.70 10.06 6.24 1.02 -8.81 6.28 -14.59 17.41 1.82 -4.48 -2.14 -2.58 -22.69 -1.25 20.81 -16.95 24.83 -1.91 -3.22
% of Revenue 10.58 11.66 12.57 12.59 11.47 9.60 9.88 8.67 10.56 11.81 11.46 11.27 11.15 8.81 8.84 10.85 9.24 11.47 11.23 10.70

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista